Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

652
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
652
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

634
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
634
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

729
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
729
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

650
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
650
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

664
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
664

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Creutzfeld Jacob disease.

QJM : monthly journal of the Association of Physicians·2017
Same author

Toxic effects of hydrogen sulfide: experience with three simultaneous patients.

QJM : monthly journal of the Association of Physicians·2015
Same author

Medical management of patients with peripheral arterial disease.

International angiology : a journal of the International Union of Angiology·2014
Same author

Prevention and treatment of venous thromboembolism--International Consensus Statement.

International angiology : a journal of the International Union of Angiology·2014
Same author

Deep venous thrombosis: rate of spontaneous lysis and thrombus extension.

International angiology : a journal of the International Union of Angiology·2004
Same author

Efficacy and safety of cerivastatin for type 2 diabetes and hypercholesterolaemia. Hyperlipidaemia in Diabetes Mellitus investigators.

Journal of cardiovascular risk·2000
Same journal

Automated three-dimensional ultrasound surveillance after endovascular aortic repair.

International angiology : a journal of the International Union of Angiology·2026
Same journal

Dose-dependent effects of rosuvastatin in deep vein thrombosis: a retrospective cohort study.

International angiology : a journal of the International Union of Angiology·2026
Same journal

Medical treatment versus endarterectomy for symptomatic carotid stenosis: systematic review and meta-analysis. Do we need an updated randomized trial to compare carotid intervention to best medical therapy in patients with symptomatic carotid disease?

International angiology : a journal of the International Union of Angiology·2026
Same journal

Pharmacological thromboprophylaxis after varicose vein thermal ablation in Spain: a national survey.

International angiology : a journal of the International Union of Angiology·2026
Same journal

Effects of information platform-based nursing management on patients with venous thromboembolism: a systematic review and meta-analysis.

International angiology : a journal of the International Union of Angiology·2026
Same journal

Outcomes of endovascular revascularization of upper limb thromboangiitis obliterans via palmar arch angioplasty.

International angiology : a journal of the International Union of Angiology·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Statins and peripheral arterial disease.

A Markel1

  • 1Department of Internal Medicine A, Haemek Medical Center, Afula, Israel - markel_ar@clalit.org.il.

International Angiology : a Journal of the International Union of Angiology
|November 21, 2014
PubMed
Summary
This summary is machine-generated.

Statins effectively treat peripheral arterial disease (PAD) by reducing cholesterol and slowing atherosclerotic plaque growth. These drugs also decrease cardiovascular events and improve walking ability in PAD patients.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K

Related Experiment Videos

Last Updated: Apr 20, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

14.3K

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Pharmacology

Background:

  • Peripheral arterial disease (PAD) involves atherosclerosis in lower limb arteries, a significant cause of morbidity.
  • Intermittent claudication (IC) is a common symptom, but many PAD patients are asymptomatic or have atypical symptoms.
  • Hypercholesterolemia is a primary risk factor for atherosclerosis, necessitating effective cholesterol-lowering strategies.

Purpose of the Study:

  • To review the efficacy of statins in managing peripheral arterial disease (PAD).
  • To explore the impact of statins on atherosclerotic plaque progression and cardiovascular events in PAD patients.
  • To evaluate the benefits of statins on functional outcomes like walking distance in PAD.

Main Methods:

  • Review of studies investigating statin use in patients with peripheral arterial disease.
  • Analysis of data on cholesterol reduction, plaque regression, and cardiovascular event rates.
  • Assessment of clinical outcomes including pain-free walking distance and ankle-brachial index.

Main Results:

  • Statins effectively reduce total and LDL cholesterol, crucial for managing hypercholesterolemia.
  • Statin administration in PAD patients demonstrates decreased atherosclerotic plaque progression and potential regression.
  • Statins reduce the incidence of coronary events and stroke, and improve walking distance and ankle-brachial index.

Conclusions:

  • Statins are strongly recommended for cholesterol reduction in PAD patients, aligning with guidelines for other cardiovascular diseases.
  • The pleiotropic effects of statins, including anti-inflammatory properties, contribute to reduced cardiovascular mortality.
  • Current evidence supports statin therapy for improving both clinical symptoms and cardiovascular outcomes in PAD.